A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’ for psychiatrists and neurologists?

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

(2019) Oliver Preische et al.   NATURE MEDICINE

Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases

(2018) Inga Zerr et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

OUP accepted manuscript

(2018)   BRAIN

The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias

(2018) Samir Abu-Rumeileh et al.   Alzheimers Research & Therapy

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

(2017) Lauren M Byrne et al.   LANCET NEUROLOGY

Serum neurofilament light in familial Alzheimer disease

(2017) Philip S.J. Weston et al.   NEUROLOGY

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

(2017) Niklas Mattsson et al.   JAMA Neurology

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis

(2017) Alessandra Gaiani et al.   JAMA Neurology

Younger Onset Dementia

(2016) Janet Sansoni et al.   American Journal of Alzheimers Disease and Other Dementias

Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders

(2016) Aidong Yuan et al.   BRAIN RESEARCH BULLETIN

Time to diagnosis in young-onset dementia and its determinants: the INSPIRED study

(2016) Brian Draper et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

(2016) Jonathan D. Rohrer et al.   NEUROLOGY

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

(2016) Henrik Zetterberg et al.   JAMA Neurology

Psychiatric Symptoms in Frontotemporal Dementia: Epidemiology, Phenotypes, and Differential Diagnosis

(2015) Daniela Galimberti et al.   BIOLOGICAL PSYCHIATRY

Comparing neurocognition in severe chronic schizophrenia and frontotemporal dementia

(2014) Hui-Minn Chan et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

(2014) T. Skillback et al.   NEUROLOGY

Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients

(2014) Joel Jakobsson et al.   NEUROPSYCHOPHARMACOLOGY

CSF biomarker variability in the Alzheimer's Association quality control program

(2013) Niklas Mattsson et al.   Alzheimers & Dementia

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

(2013) Carole S. Scherling et al.   ANNALS OF NEUROLOGY

The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease

(2011) Josh D. Woolley et al.   JOURNAL OF CLINICAL PSYCHIATRY

The diagnosis of young-onset dementia

(2010) Martin N Rossor et al.   LANCET NEUROLOGY

Is there a CSF biomarker profile related to depression in elderly women?

(2010) Pia Gudmundsson et al.   PSYCHIATRY RESEARCH

Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases

(2009) D. Velakoulis et al.   BRITISH JOURNAL OF PSYCHIATRY

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

(2009) Kathryn A Ellis et al.   INTERNATIONAL PSYCHOGERIATRICS

Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond

(2009) E. Bora et al.   SCHIZOPHRENIA BULLETIN